Navigation Links
The Scripps Research Institute Names Michael A. Marletta as President
Date:2/25/2011

ous MacArthur Fellowship—has focused his research on the intersection of chemistry and biology. He is acknowledged as a pioneer in discovering the role of nitric oxide, a critical player in communication between cells.

Lerner, who will continue to lead his groundbreaking research program at the Institute after his tenure as president, said, "Please join me in welcoming Michael Marletta to Scripps Research. I have great confidence in his abilities and look forward to working with him during the transition and beyond. Given Michael's expertise, we can be secure in the knowledge that the flagship programs of the Institute will continue to thrive."

"We are extremely pleased to announce Michael Marletta as the next president of The Scripps Research Institute," said Lawrence C. Horowitz, MD, member of the Board of Trustees and Chair of the Presidential Search Committee, who spoke on behalf of the Committee as a whole. "His extensive and distinguished professional background, passion for science and education, and ability to lead strategically embody the ideal mix of talent and vision to carry Scripps Research into the future."

Horowitz added that the Board is deeply grateful to Lerner for his extraordinary contributions, and expresses confidence Lerner and Marletta will work together to assure a seamless transition.

Celebrations welcoming Marletta, honoring Lerner, and marking the 50th anniversary of the institute's focus on biomedical research are planned throughout the year.

About Michael Marletta

Michael A. Marletta was born in Rochester, New York, in 1951. After completing an AB at the State University of New York (SUNY), Fredonia, (1973), a PhD from UC San Francisco (1978) with George L. Kenyon, and a postdoctoral fellowship at the Massachusetts Institute of Technology (MIT, 1978 - 80) with Christopher T. Walsh, he joined the faculty at MIT as assistant professor in 1980. He was promoted to associate professor i
'/>"/>

SOURCE Scripps Research Institute
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
2. Quest Diagnostics Brings Genetic Testing for Plavix(R) Response to Coronary Stent Patients at Scripps Health
3. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
4. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
5. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
6. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
7. Video: New Research Discovers Independent Brain Networks Control Human Walking
8. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
9. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
10. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
11. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 17, 2014 , ... a hub of information concerning the biopharmaceutical Group,s national and ... further addition to the recently launched institutional website that is ... been enriched by a new chapter in the fascinating story ... richly detailed and panoramic hub on the world of clinical ...
(Date:12/17/2014)... 17, 2014  IGI Laboratories, Inc. (NYSE MKT: IG; ... its offering of $125 million aggregate principal amount of ... Notes were offered and sold only to qualified institutional ... of 1933, as amended (the "Securities Act"). ... 3.75% per year, payable semiannually in arrears on June ...
(Date:12/17/2014)... and RALEIGH, N.C. , ... Communications, LLC (CTMC), and Integrated Clinical Trial Services, ... and retention for clinical trials announce that they ... Trial Marketing Services (i-CTMS). i-CTMS will provide a ... to pharmaceutical, biotechnology and medical device companies. ...
Breaking Medicine Technology:Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3
... PARSIPPANY, N.J., Nov. 30, 2011  Watson Pharmaceuticals, Inc. (NYSE: ... Inc., has launched an authorized generic version of LIPITOR® ... exclusive agreement with Pfizer Inc.  Watson began shipping the ... adjunct to diet to reduce elevated total cholesterol, LDL, ...
... 2011  Vantage Health (OTC:BB – ticker symbol VNTH), ("Company"), ... Health Tanzania Limited ("VHTL"), was awarded Lot 1, Lot ... es Salaam ("University") pharmaceutical and medical supply tender number ... value for lot 1, lot 2 and lot 3 ...
Cached Medicine Technology:Watson Launches Generic LIPITOR® 2Watson Launches Generic LIPITOR® 3Vantage Health 51% Owned Tanzanian Subsidiary Awarded Lot 1, Lot 2 and Lot 3 of University of Dar Es Salaam Pharmaceutical and Medical Supply Tender 2Vantage Health 51% Owned Tanzanian Subsidiary Awarded Lot 1, Lot 2 and Lot 3 of University of Dar Es Salaam Pharmaceutical and Medical Supply Tender 3
(Date:12/19/2014)... Santa Rosa, CA (PRWEB) December 19, 2014 ... 2x4 and 5x5 SuperClone Rooms. SuperCloset continues to offer ... grow solutions. Pair one of the new SuperClone Rooms ... truly professional, perpetual, and turnkey indoor hydroponic grow room ... cloner in the world, SuperCloset’s SuperPonic SuperCloner 50 ...
(Date:12/19/2014)... The Medspa at Hendrick in Abilene, TX presents ... brand Juvéderm. Voluma XC treats volume loss in cheeks, ... Hendrick is pleased to be able to offer this ... clients. , Voluma is the first and only injectable ... mid-face and cheek area. This non-invasive treatment targets volume ...
(Date:12/19/2014)... FRIDAY, Dec. 19, 2014 (HealthDay News) -- All children ... 3 and 6, preferably every year, eye experts say. ... from an expert panel of the U.S. National Center ... children in this age group require screening for eye ... glasses, such as amblyopia ("lazy eye") and strabismus (a ...
(Date:12/19/2014)... Dec. 19, 2014 (HealthDay News) -- The cost of ... well-being, a new study finds. Researchers examined data ... been diagnosed with colorectal or lung cancer. Of those ... cancer-free, and more than 100 had advanced cancer. ... to pay their medical bills, which was linked with ...
(Date:12/19/2014)... Dennis Thompson HealthDay Reporter ... Ebola,s entrance into the United States -- along with ... outbreak -- have highlighted cracks in the nation,s public ... health policy report released Thursday. Half of U.S. ... to infectious disease outbreaks. That was the main conclusion ...
Breaking Medicine News(10 mins):Health News:SuperCloset Continues to Innovate with New Complete Indoor Grow Room Packages, The SuperClone Rooms are the Newest Addition to the Award Winning SuperRoom Lineup 2Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2Health News:Preschoolers Need Eye Screening, Experts Say 2Health News:Cancer Treatment Costs Weigh Heavily on Patients, Study Finds 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 3Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 4
... Blue companies, stewardship of,healthcare dollars, WASHINGTON, June ... investigations resulted in overall savings and,recoveries of more ... released,by the Blue Cross and Blue Shield Association ... Blue Cross and Blue Shield companies, anti-fraud,units was ...
... HARRISBURG, Pa., June 19 Four illnesses,caused ... State Health Secretary Dr. Calvin B. Johnson announced ... Salmonella outbreak,associated with tomatoes that has produced at ... has been identified in Bucks, Butler, Lancaster, and,Warren ...
... year, the ESMO International Symposium: 10th World ... from 6 leading professional societies and organizations, ... the premier platform for specialists in cancer ... review the state-of-the-art in gastrointestinal cancer and ...
... the Necessity of ... Healthcare ... to gauge,healthcare professionals, attitudes about universal coverage and the,candidates, programs, ... the U.S. A nationwide,representative sample of 336 general practitioners, internal ...
... - Adds $47 million in annual revenues and eight locations in ... Connecticut, ... Inc.,(Nasdaq: AFAM ), a leading regional provider of home health ... the stock of Patient Care, Inc. This acquisition, the Company,s,largest to ...
... Schmidt teams up with Minor League Baseball(TM) to raise awareness of, ... ... in the U.S., BRIDGEWATER, N.J., June 19 Hall of Fame ... teamed up to launch BPH Game Plan Starts with U:,Catch the Whole ...
Cached Medicine News:Health News:Blue Cross and Blue Shield Companies' Anti-Fraud Units Recover and Save More Than $249 Million In 2007 2Health News:Blue Cross and Blue Shield Companies' Anti-Fraud Units Recover and Save More Than $249 Million In 2007 3Health News:Pennsylvania Department of Health Investigates Salmonella Cases Linked to National Outbreak 2Health News:10th World Congress on Gastrointestinal Cancer -- Barcelona, Spain 2Health News:U.S. Healthcare Professionals Speak Out on Universal Healthcare and the Presidential Candidates' Platforms 2Health News:U.S. Healthcare Professionals Speak Out on Universal Healthcare and the Presidential Candidates' Platforms 3Health News:U.S. Healthcare Professionals Speak Out on Universal Healthcare and the Presidential Candidates' Platforms 4Health News:U.S. Healthcare Professionals Speak Out on Universal Healthcare and the Presidential Candidates' Platforms 5Health News:Almost Family, Inc. Signs Definitive Agreement to Acquire Patient Care, Inc. 2Health News:Almost Family, Inc. Signs Definitive Agreement to Acquire Patient Care, Inc. 3Health News:Almost Family, Inc. Signs Definitive Agreement to Acquire Patient Care, Inc. 4Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 2Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 3Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 4Health News:Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men 5
Low-profile, hand-held instrument....
Low-profile, hand-held instrument....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
... Nephew ECTRA II systems permit the surgeon ... ligament endoscopically, allowing access via two portals ... endoscopic lens fogging with good air flow. ... and control. ECTRA knives permit the surgeon ...
Medicine Products: